Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines

European Journal of Immunology

Volumn 30, Issue 2, 2000, Pages 671-677

  Sherritt, Martina A ^a   Gardner, Joy ^a   Elliott, Suzanne L ^a   Schmidt, Christopher ^a   Purdie, David ^b   Deliyannis, Georgia ^c   Heath, William R ^d   Suhrbier, Andreas ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Cytotoxic T lymphocyte; Immunodominance; Polytope; Therapeutic vaccine

Indexed keywords

CD8 ANTIGEN; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MELANOMA; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

EID: 0033976503     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200002)30:2<671::AID-IMMU671>3.0.CO;2-H     Document Type: Article

References (36)

1. Yewdell, J. W. and Bennink, J. R., Immunodominance in MHC class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 1999. 17: 51-88.
2. Busch, D. H. and Pamer, E. G., MHC class I/peptide stability: implications for immunodominance, in vitro proliferation, and diversity of responding CTL. J. Immunol. 1998. 160: 4441-4448.
3. Schmidt, C., Burrows, S. R., Sculley, T. B., Moss, D. J. and Misko, I. S., Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: impliciations for vaccine strategies. Proc. Natl. Acad. Sci. USA 1991. 88: 9478-9482.
4. Busch, D. H., Pilip, I. M., Vijh, S. and Pamer, E. G., Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998. 8: 353-362.
5. Van Waes, C., Monach, P. A., Urban, J. L., Wortzel, R. D. and Schreiber, H., Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro. Tissue Antigens 1996. 47: 399-407.
6. + T cell epitopes, virus load, and kinetics of primary antiviral CTL response. J. Immunol. 1998. 160: 2923-2931.
7. Brichard, V. G., Warnier, G., Van Pel, A., Morlighem, G., Lucas, S. and Boon, T., Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815. Eur. J. Immunol. 1995. 25: 664-671.
8. Sandberg, J. K., Grufman, P., Wolpert, E. Z., Franksson, L., Chambers, B. J. and Karre, K., Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 1998. 160: 3163-3169.
9. McMichael, A. J. and O'Callaghan, C. A., A new look at T cells. J. Exp. Med. 1998. 187: 1367-1371.
10. Etlinger, H. M., Gillessen, D., Lahm, H. W., Matile, H., Schonfeld, H. J. and Trzeciak, A., Use of prior vaccinations for the development of new vaccines. Science 1990. 249: 423-425.
11. Butz, E. A. and Bevan, M. J., Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998. 8: 167-175.
12. Klenerman, P. and Zinkernagel, R. M., Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998. 394: 482-485.
13. Baumgarth, N. and Kelso, A., In vivo blockade of gamma Interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue. J. Virol. 1996. 70: 4411-4418.
14. Belz, G. T., Altman, J. D. and Doherty, P. C., Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc. Natl. Acad. Sci. USA 1998. 95: 13812-13817.
15. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J. and Carbone, F. R., T cell receptor antagonist peptides induce positive selection. Cell 1994. 76: 17-27.
16. Thomson, S. A., Elliott, S. L., Sherritt, M. A., Sproat, K. W., Coupar, B. E., Scalzo, A. A., Forbes, C. A., Ladhams, A. M., Mo, X. Y., Tripp, R. A., Doherty, P. C., Moss, D. J. and Suhrbier, A., Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. J. Immunol. 1996. 157: 822-826.
17. Gilbert, S. C., Plebanski, M., Harris, S. J., Allsopp, C. E., Thomas, R., Layton, G. T. and Hill, A. V., A protein particle vaccine containing multiple malaria epitopes. Nat. Biotechnol. 1997. 15: 1280-1284.
18. An, L. L. and Whitton, J. L., A multivalent minigene vaccine, containing B-cell, CTL, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen. J. Virol. 1997. 71: 2292-2302.
19. Toes, R. E., Hoeben, R. C., van der Voort, E. I., Ressing, M. E., van der Eb, A. J., Melief, C. J. and Offringa, R., Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated CTL epitopes in a string-of-beads fashion. Proc. Natl. Acad. Sci. USA 1997. 94: 14660-14665.
20. + cytotoxic T cell epitopes. J. Virol. 1999. 73: 5320-5325.
21. Lake, R. A., Robinson, B. W. and Hayball, J. D., MHC multimerization, antigen expression and the induction of APC amnesia in the developing immune response. Immunol. Cell Biol. 1999. 77: 99-104.
22. Monks, C. R., Freiberg, B. A., Kupfer, H., Sciaky, N. and Kupfer, A., Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998. 395: 82-86.
23. Jameson, S. C., Hogquist, K. A. and Bevan, M. J., Positive selection of thymocytes. Annu. Rev. Immunol. 1995. 13: 93-126.
24. Njenga, M. K., Pease, L. R., Wettstein, P., Mak, T. and Rodriguez, M., Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system. Lab. Invest. 1997. 77: 71-84.
25. Hakem, R., Le Bouteiller, P., Jezo-Bremond, A., Harper, K., Campese, D. and Lemonnier, F. A., Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequences. J Immunol. 1991. 147: 2384-2390.
26. Schmidt, H., Gekeler, V., Haas, H., Engler-Blum, G., Steiert, I., Probst, H. and Muller, C. A., Differential regulation of HLA class I genes by Interferon. Immunogenetics 1990. 31: 245-252.
27. Fruh, K. and Yang, Y., Antigen presentation by MHC class I and its regulation by Interferon gamma. Curr. Opin. Immunol. 1999. 11: 76-81.
28. Knight, S. C., Askonas, B. A. and Macatonia, S. E., Dendritic cells as targets for cytotoxic T lymphocytes. Adv. Exp. Med. Biol. 1997. 417: 389-394.
29. Chapman, T. L. and Bjorkman, P. J., Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J . Virol. 1998. 72: 460-466.
30. Kurts, C., Miller, J. F., Subramaniam, R. M., Carbone, F. R. and Heath, W. R., Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 1998. 188: 409-414.
31. Sigal, L. J., Crotty, S., Andino, R. and Rock, K. L., Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 1999. 398: 77-80.
32. Albert, M. L., Sauter, B. and Bhardwaj, N., Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998. 392: 86-89.
33. Kettle, S., Alcami, A., Khanna, A., Ehret, R., Jassoy, C. and Smith, G. L., Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1 beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J. Gen. Virol. 1997. 78: 677-685.
34. + T cells mediate CD40-independent maturation of dendritic cells in vivo. J. Exp. Med. 1999. 189: 1875-1883.
35. Ogg, G. S. and McMichael, A. J., HLA-peptide tetrameric complexes. Curr. Opin. Immunol. 1998. 10: 393-396.
36. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., Slansky, J. and Ahmed, R., Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998. 8: 177-187.